Analysis

Verrica Pharmaceuticals Inc. (VRCA) Stock Analysis

Verrica Pharmaceuticals Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to VRCA.

websiteVRCA/analysis/VRCA

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to VRCA.

Stock profile

Ticker

VRCA

Asset type

Stock

Market cap

$98.4M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Verrica Pharmaceuticals Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • VRCA primary listing
  • A41A98
  • 1NE0

Latest Verrica Pharmaceuticals Inc. news

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

WEST CHESTER, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications fo...

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications fo...

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Trea...

Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmac...

Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026

WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a therapeutics company developing and commercializi...

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment...

WEST CHESTER, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and

Research sections

Valuation

Review valuation context for Verrica Pharmaceuticals Inc..

Future growth

Review future growth context for Verrica Pharmaceuticals Inc..

Past performance

Review past performance context for Verrica Pharmaceuticals Inc..

Financial health

Review financial health context for Verrica Pharmaceuticals Inc..

Dividend

Review dividend context for Verrica Pharmaceuticals Inc..

Management

Review management context for Verrica Pharmaceuticals Inc..

Ownership

Review ownership context for Verrica Pharmaceuticals Inc..

Other information

Review other information context for Verrica Pharmaceuticals Inc..

Community

Review community context for Verrica Pharmaceuticals Inc..